Kiromic BioPharma (KRBP) Stock Chart & Stock Price History → One trade. One ticker. One week. (From Wealthpin Pro) (Ad) Free KRBP Stock Alerts $2.71 +0.07 (+2.65%) (As of 04/24/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial Media Kiromic BioPharma Stock Price Performance5 Day Performance+4.23%1 Month Performance-6.39%3 Month Performance+68.32%6 Month Performance+942.31%Year-To-Date Performance+211.49%1 Year Performance-31.39% Receive KRBP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Kiromic BioPharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad WealthPress$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge. KRBP Stock Chart for Thursday, April, 25, 2024 KRBP Chart by TradingView Kiromic BioPharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/24/2024$2.64$2.71+2.65%$2.95$2.641,584 shs$3.50 million04/23/2024$2.60$2.64+1.54%$2.64$2.47355 shs$3.41 million04/22/2024$2.60$2.60$2.60$2.602,676 shs$3.35 million04/19/2024$2.50$2.60+4.00%$2.60$2.55716 shs$3.35 million04/18/2024$2.30$2.50+8.70%$2.50$2.50834 shs$3.23 million04/17/2024$2.91$2.30-20.96%$3.13$2.2515,369 shs$2.96 million Get the Latest News and Ratings for KRBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kiromic BioPharma and its competitors with MarketBeat's FREE daily newsletter. 04/16/2024$2.81$2.91+3.56%$2.91$2.91149 shs$3.75 million04/15/2024$2.94$2.81-4.39%$2.90$2.81458 shs$3.63 million04/12/2024$2.75$2.94+6.87%$2.96$2.94316 shs$3.79 million04/11/2024$2.27$2.75+21.15%$2.75$2.7584 shs$3.55 million04/10/2024$2.27$2.27$2.27$2.27475 shs$2.93 million04/09/2024$2.35$2.27-3.40%$2.57$2.27475 shs$2.93 million04/08/2024$2.35$2.35$3.05$1.71958 shs$3.03 million04/05/2024$2.90$2.35-18.97%$2.63$2.35958 shs$3.03 million04/04/2024$2.85$2.90+1.75%$3.00$2.786,933 shs$3.74 million04/03/2024$3.00$2.85-5.00%$3.00$1.957,397 shs$3.68 million04/02/2024$3.00$3.00$3.00$2.858,380 shs$3.87 million04/01/2024$2.85$3.00+5.26%$3.13$2.858,380 shs$3.87 million03/29/2024$2.85$2.85$3.04$2.855,627 shs$3.68 million03/28/2024$2.77$2.85+2.89%$3.04$2.855,627 shs$3.68 million03/27/2024$3.07$2.77-9.74%$3.09$2.771,537 shs$3.57 million03/26/2024$2.90$3.07+6.01%$3.07$2.883,657 shs$3.96 million03/25/2024$3.01$2.90-3.82%$3.00$2.9012,031 shs$3.74 million03/22/2024$2.80$3.01+7.35%$3.20$2.855,358 shs$3.88 million03/21/2024$2.75$2.80+1.96%$2.80$2.75606 shs$3.62 million03/20/2024$2.83$2.75-2.83%$3.21$2.751,675 shs$3.55 million03/19/2024$2.34$2.83+20.94%$3.65$2.7710,610 shs$3.65 million03/18/2024$1.49$2.34+57.58%$2.95$1.5911,386 shs$3.02 million03/15/2024$2.05$1.49-27.47%$1.80$1.361,240 shs$1.92 million03/14/2024$1.55$2.05+32.10%$2.05$1.2511,694 shs$2.64 million03/13/2024$2.10$1.55-26.19%$1.89$1.551,612 shs$2.00 million03/12/2024$1.99$2.10+5.53%$2.10$2.102,028 shs$2.71 million03/11/2024$2.00$1.99-0.50%$2.25$1.7012,755 shs$2.57 million03/08/2024$2.35$2.00-14.89%$2.20$2.002,216 shs$2.58 million03/07/2024$2.62$2.35-10.31%$2.75$2.354,658 shs$3.03 million03/06/2024$2.98$2.62-12.08%$2.98$2.354,208 shs$3.38 million03/05/2024$2.67$2.98+11.61%$2.98$2.98183 shs$3.84 million03/04/2024$2.36$2.67+13.14%$3.00$2.653,083 shs$3.44 million03/01/2024$2.61$2.36-9.40%$2.50$2.351,472 shs$3.04 million02/29/2024$2.89$2.61-9.78%$2.88$2.256,252 shs$3.36 million$25,000 into $109,616 in two months? (Ad)Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge.02/28/2024$3.00$2.89-3.75%$3.05$2.852,182 shs$3.73 million02/27/2024$3.11$3.00-3.54%$3.34$3.004,097 shs$3.87 million02/26/2024$3.46$3.11-10.12%$3.47$3.053,873 shs$4.01 million02/23/2024$3.35$3.46+3.28%$3.60$3.303,778 shs$4.46 million02/22/2024$3.39$3.35-1.18%$3.78$3.3117,881 shs$4.32 million02/21/2024$3.02$3.39+12.25%$3.39$3.186,358 shs$4.37 million02/20/2024$2.94$3.02+2.69%$3.66$2.9010,551 shs$3.90 million02/19/2024$2.94$2.94$3.78$2.9124,700 shs$3.79 million02/16/2024$3.41$2.94-13.76%$3.78$2.9124,760 shs$3.74 million02/15/2024$2.56$3.41+33.08%$3.45$2.5522,824 shs$4.35 million02/14/2024$1.85$2.56+38.51%$3.13$2.1071,417 shs$3.27 million02/13/2024$1.72$1.85+7.71%$1.85$1.741,844 shs$2.35 million02/12/2024$1.63$1.72+5.37%$1.75$1.674,314 shs$2.18 million02/09/2024$1.56$1.63+4.49%$1.65$1.636,760 shs$2.05 million02/08/2024$1.56$1.56$1.57$1.501,350 shs$1.97 million02/07/2024$1.55$1.56+0.65%$1.56$1.56280 shs$1.97 million02/06/2024$1.61$1.55-3.73%$1.65$1.554,981 shs$1.95 million02/05/2024$1.35$1.61+19.26%$1.65$1.387,569 shs$2.03 million02/02/2024$1.26$1.35+7.14%$1.44$1.263,878 shs$1.70 million02/01/2024$1.29$1.26-2.33%$1.35$1.262,354 shs$1.59 million01/31/2024$1.25$1.29+3.20%$1.54$1.263,824 shs$1.63 million01/30/2024$1.77$1.25-29.38%$1.66$1.2519,184 shs$1.58 million01/29/2024$1.50$1.77+18.00%$1.78$1.4022,370 shs$2.23 million01/26/2024$1.61$1.50-6.83%$1.77$1.504,827 shs$1.89 million01/25/2024$1.61$1.61$1.62$1.475,255 shs$2.03 million01/24/2024$1.64$1.61-1.83%$1.65$1.555,255 shs$2.03 million Related Companies: NSTGQ Stock Chart TCON Stock Chart ALBT Stock Chart ELOX Stock Chart GMDAQ Stock Chart FNCH Stock Chart PALI Stock Chart GMDA Stock Chart WINT Stock Chart FRTX Stock Chart Receive KRBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kiromic BioPharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KRBP) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American Alternative1970’s computer coder issues shocking A.I. warningTradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kiromic BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.